Robert Green
Ophthalmology · San Antonio, TXNPI 1528075801
Payments from drug & device makers
Across 84 payments — averaging $40.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$568
- AbbVie$551
- Johnson & Johnson Surgical Vision, Inc.$302
- Rxsight Inc$249
- Bausch & Lomb Americas Inc.$245
- Bausch & Lomb, A Division Of Bausch Health US, LLC$189
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,35199%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 12 | $568 |
| AbbVie(2 entities) | 17 | $551 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $302 |
| Rxsight Inc | 4 | $249 |
| Bausch & Lomb Americas Inc. | 8 | $245 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $189 |
| Glaukos Corporation | 5 | $156 |
| Astellas Pharma US Inc | 2 | $147 |
| Sight Sciences, Inc. | 1 | $137 |
| Tarsus Pharmaceuticals, Inc. | 2 | $134 |
| Aerie Pharmaceuticals, Inc. | 2 | $117 |
| Genentech USA, Inc. | 1 | $117 |
| Acumed LLC | 1 | $107 |
| Sun Pharmaceutical Industries Inc. | 4 | $103 |
| Biotissue Holdings Inc. | 2 | $95 |
| Amgen | 5 | $74 |
| Ocular Therapeutix, Inc. | 1 | $29 |
| Dompe US, Inc. | 1 | $21 |
| Rayner Intraocular Lenses Limited | 1 | $19 |
| Lensar, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$279
- DURYSTA$260
- Tecnis Simplicity$219
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$144
- OMNI(R) SURGICAL SYSTEM (US)$137
- Centurion$134
- Izervay$127
- MIEBO$125
- XIIDRA$125
- Tecnis IOL$117
- VERITAS Vision System$117
- Lucentis$117
- XDEMVY$110
- ACUMED$107
How this compares
$3,369 in reported general payments places this provider in the 60th percentile of 1,355 ophthalmology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyzultaLatanoprostene Bunod | 15 | $5,386 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 96 | $1,265 |
| Latanoprost | 96 | $1,003 |
| Brimonidine Tartrate | 13 | $297 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Vyzulta | $245 | $5,38615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,355 ophthalmology providers in Texas.
Other ophthalmology in San Antonio
- Michael SingerSan Antonio$4.2M
- Gregory ParkhurstSan Antonio$4.1M
- Calvin MeinSan Antonio$1.3M
- James LehmannSan Antonio$1.1M
- Darren BellSan Antonio$906K
- Gregory BruninSan Antonio$709K
- Richard EvansSan Antonio$656K
- Edward RashidSan Antonio$523K
- Kenneth MaverickSan Antonio$485K
- Kundandeep NagiSan Antonio$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.